Trial
NCT02626169
The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Baylor College of Medicine
Collaborators
—
Condition
Atherosclerosis
Intervention
Clopidogrel
Why stopped
Pharmaceutical company sponsor withdrew support prior to enrollment of subjects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-11